Aug 2026· 2026 International Conference on Modern Sustainable Systems (CMSS)· pp. 1404-1407· 0 citations· 21 references
Abstract
Deep learning has changed how images and text are analyzed, and it is now widely used on gene expression data as well. This paper asks a direct question. On a standard cancer classification task from RNA-Seq expression, does deep learning actually beat simple machine learning, and when does the difference show up. We use the public TCGA pan-cancer RNA-Seq dataset, with 801 samples across five tumor types and more than 20000 genes. We build three neural models, a multilayer perceptron, a one-dimensional convolutional network, and an autoencoder paired with a softmax classifier, and we compare them with a random forest and a linear support vector machine. Every model is tested with stratified 5-fold cross-validation repeated over three seeds. On the full data the models are close. The multilayer perceptron reaches a macro F1 of 0.9996, matching the linear support vector machine and slightly ahead of the random forest, while the convolutional network trails at 0.920 because the gene axis has no spatial order for a convolution to use. The clearer story appears when labels are scarce. With only about 28 labeled samples the multilayer perceptron leads the random forest by roughly two points, and the gap closes as data grows. The lesson is that a plain neural network is a strong and honest baseline here, that convolution needs a matching structure to help, and that the value of deep learning on this task is largest when labels are few.
Accurate characterization of tumor subtype is of paramount importance in guiding treatment decisions in pediatric cancers. Here, we present FRANK (Fully-connected RNA-based Augmentation Neural Klassifier), a machine learning approach for classifying pan-cancer pediatric tumors. We curated a set of 11,467 transcriptomes...
K. Sablauskas, T. Kiseļova, L. Bardina et al.· medRxiv· 0 citations
DeepCelllify is introduced, a novel deep learning-based framework that harnesses convolutional neural networks (CNNs) to classify patients using their individual cell expression profiles, and demonstrates competitive performance compared to state-of-the-art approaches.
A. Oulas, N. Karathanasis, T. Lampadarios et al.· Frontiers in Bioinformatics· 0 citations
DNA sequencing of the gut microbial community shows promise for cancer detection, but questions remain about the generalizability of results across studies. We propose BreCol, a benchmark of 2,040 16S rRNA gene sequencing runs across 26 studies spanning breast cancer, colorectal cancer, and healthy cohorts. Train-test...
Background Tissue microarray (TMA) technology is pivotal in cancer research, enabling simultaneous analysis of multiple samples on a single slide. Manual analysis of TMA images remains time-consuming and subjective. This study aimed to develop a robust deep learning model to automate TMA image analysis, enhance accurac...
Kuo-Wang Tsai, Bach-Tung Pham, Ching-Feng Cheng et al.· Journal of Cancer· 0 citations